This week in optometry: December 11-December 15

News
Article

Catch up on what happened in optometry during the week of December 11-December 15.

Catch up with what Optometry Times® shared this week:

FDA approves iDose TR from Glaukos for reduction of IOP and ocular hypertension

David Hutton, Managing Editor, Ophthalmology Times

iDose TR, a micro-invasive intraocular implant designed to lower IOP in patients with open-angle glaucoma or ocular hypertension, has received FDA approval following a new drug application (NDA) submission.

Read more...

Parental perspectives on myopia unveiled by The Vision Council

Emily Kaiser Maharjan, Assistant Managing Editor

A research report compiled by The Vision Council reveals that most parents are aware of myopia but remain in the dark about prevalence and how to prevent progression.

Read more...

New tools emerge for the early detection of hydroxychloroquine maculopathy

Kyra Dorgeloh, OD, FAAO; Leena Walker, OD, FAAO

Hydroxychloroquine is considered to have a favorable systemic safety profile, even for long-term use, but poses the risk for retinal toxicity and irreversible vision loss.

Read more...

Topline results from Ersa Phase 2a trial revealed by Tarsus

Martin David Harp, Associate Editor, Ophthalmology Times

TP-03 (lotilaner ophthalmic solution, 0.25%) was approved by the FDA in 2023 under the brand name Xdemvy for the treatment of Demodex blepharitis and is being evaluated as an investigational therapy for the treatment of Meibomian Gland Disease (MGD) in patients with Demodex mites.

Read more...

2023 in review: A review of FDA approvals in eye care this year

Martin David Harp, Associate Editor, Ophthalmology Times; Emily Kaiser Maharjan, Assistant Managing Editor

Eye care witnessed a transformative year with 11 FDA approvals. As the year concludes, there remains a robust pipeline of drugs, setting high expectations for continued advancements in ophthalmological care in 2024 and beyond.

Read more...

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Arkansas Optometric Association legislative cochairs Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD, discuss their involvement in their bill and provide context for its relevance.
Elise Kramer, OD, FAAO, FSLS, describes her take on a multidisciplinary approach to dry eye
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Paul Karpecki, OD, FAAO
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
© 2025 MJH Life Sciences

All rights reserved.